These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9574835)

  • 21. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    J Clin Endocrinol Metab; 1998 Feb; 83(2):348-52. PubMed ID: 9467539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal polypeptide enhances ACTH levels in some patients with adrenocorticotropin-secreting pituitary adenomas.
    Ambrosi B; Bochicchio D; Sartorio A; Morabito F; Faglia G
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):216-20. PubMed ID: 2821720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
    Duclos M; Corcuff JB; Roger P; Tabarin A
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH.
    Croughs RJ; Zelissen PM; van Vroonhoven TJ; Hofland LJ; N'Diaye N; Lacroix A; de Herder WW
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):235-40. PubMed ID: 10671952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.
    Nieman LK; Chrousos GP; Oldfield EH; Avgerinos PC; Cutler GB; Loriaux DL
    Ann Intern Med; 1986 Dec; 105(6):862-7. PubMed ID: 3022629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.
    Ritzel K; Beuschlein F; Berr C; Osswald A; Reisch N; Bidlingmaier M; Schneider H; Honegger J; Geyer LL; Schopohl J; Reincke M
    Eur J Endocrinol; 2015 Aug; 173(2):197-204. PubMed ID: 25953828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide exerts different effects in vivo and in vitro in Cushing's disease.
    Stalla GK; Brockmeier SJ; Renner U; Newton C; Buchfelder M; Stalla J; Müller OA
    Eur J Endocrinol; 1994 Feb; 130(2):125-31. PubMed ID: 8130885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of Different ACTH and Cortisol Concentration Values in Corticotropin-Releasing Hormone Based Tests in Cushing's Disease.
    Sobeh Khalil S; Sheikh Ahmad M; Sarah-Hefer T; Yovanovich E; Reut M; Chen-Konak L; Saba-Khazen N; Saiegh L
    Endocr Res; 2023 Feb; 48(1):27-34. PubMed ID: 36781417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
    Yamada Y; Ohashi A; Inoue T; Sakaguchi K; Tsujimura T; Okamoto D; Itatani H; Fujimoto N; Kusaka K; Fushimi H
    Intern Med; 2002 Jul; 41(7):549-54. PubMed ID: 12132523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.